Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic acid for cognitive dysfunction in stabilised primary biliary cholangitis
ISRCTN15223158Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of obeticholic acid in primary biliary cholangitis (PBC), sponsored by Newcastle Hospitals NHS Foundation Trust. Started Apr 2021; status: completed.
02
Drugs
obeticholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on ISRCTN15223158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15223158.